29
2023
-
11
The volume and scale of surgeries in China’s trauma and orthopedics industry are steadily growing, while market concentration continues to rise.
1. Overview of Trauma Orthopedic Implants
Trauma orthopedics primarily refers to conditions caused by external forces or injuries sustained by patients, such as fractures of the limbs, lumbar vertebral fractures, joint dislocations, ligament injuries of the joints, meniscus tears, and soft-tissue injuries of muscles. These injuries are broadly categorized into limb trauma, pelvic trauma, spinal trauma, joint trauma, and other open-type traumas. Different products are used depending on the specific type of injury; the main products include intramedullary nails, hollow screws, conventional nail-plate systems, and locking nail-plate systems, which are employed for fixation in areas such as the limbs, pelvis, and spine.
2. Analysis of the Volume of Trauma Orthopedic Surgeries in China
In recent years, as urbanization has accelerated, the volume of construction projects has increased, leading to a corresponding rise in the number of safety accidents. As of 2022, China had experienced 549 incidents involving production safety in housing and municipal engineering projects, resulting in 622 fatalities, thereby boosting demand for trauma surgery. Meanwhile, amid an aging society and a large total population, the number of trauma cases—such as falls among the elderly, traffic accidents, and other accidental injuries—is on the rise. Moreover, as the scope of social insurance continues to expand, an increasing number of trauma surgeries are being covered by medical insurance, further driving up the volume of such procedures. According to available data, in 2021, China performed approximately 2.96 million trauma-related surgeries, with a compound annual growth rate (CAGR) of 11.1% from 2012 to 2021.
3. Analysis of the Size of China’s Trauma-Related Orthopedic Market
Therefore, as the volume of trauma surgeries continues to grow, the market size is also expanding rapidly. According to data, from 2012 to 2021, China’s trauma market grew from 3.4 billion yuan to 10.4 billion yuan, with a compound annual growth rate of 13.2%, maintaining steady and rapid growth.
4. Competitive Analysis of the Trauma Orthopedics Market in China
Currently, the Chinese trauma orthopedics market exhibits low concentration. In 2019, Johnson & Johnson, the company with the highest market share, held a 14.2% share, while the leading domestic companies, Dabao and Weigao, accounted for only 7.8% and 4.7%, respectively, indicating a relatively fragmented market structure. However, due to the national implementation of procurement measures for orthopedic consumables, small and medium-sized enterprises as well as imported companies in the trauma orthopedics sector have been forced to exit the market, thereby driving a continuous increase in market concentration. According to available data, China’s CR5—the concentration ratio of the top five players—in the trauma orthopedics implant consumables market rose from 29.1% in 2012 to 40.0% in 2019.
Moreover, trauma surgery places high demands on inventory completeness and timeliness of response, with secondary hospitals being the primary providers. As a result, companies are required to have strong capabilities in optimizing inventory, coordinating logistics, and deepening distribution channels—capabilities that give local enterprises a distinct advantage. Currently, although imported companies still hold a significant share of the trauma care market segment, domestic substitution has largely been completed. In the future, as market concentration increases and companies’ R&D capabilities improve, the market share held by imported firms will be gradually eroded by domestic competitors.